Company Search:
Advanced Search
Sponsored Links
Novartis AG - ADR Company Snapshot
Novartis AG operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Novartis AG with three other companies in this sector in the United States: Pfizer Inc. (2019 sales of $51.75 billion ), Merck & Co. , Inc. ($46.84 billion ), and GlaxoSmithKline plc ($43.18 billion ).

Sales Analysis. Novartis AG reported sales of $48.62 billion for the year ending December of 2019. This represents a decrease of 8.5% versus 2018, when the company's sales were $53.17 billion. The sales level in 2019 was fairly close to the level five years ago: in 2014, Novartis AG had sales of $53.33 billion. Contributing to the drop in overall sales was the 1.3% decline in Sandoz, from $9.86 billion to $9.73 billion. . However, these declines were partially offset by the increase in sales of Innovative Medicines (up 8.1% to $37.71 billion) .
  Stock Performance Chart for Novartis AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (2/14/2020): 97.63
(Figures in U.S. Dollars)
1 Week 1.9%   13 Weeks 1.8%  
4 Weeks 8.4%   52 Weeks 8.6%  
Novartis AG - ADR Key Data:
  Ticker: NVS Country: United States
  Exchanges: NYSE Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 48,624,153,000
(Year Ending Jan 2020).
Employees: 103,914
  Currency: U.S. Dollars Market Cap: 221,132,778,683
  Fiscal Yr Ends: December Shares Outstanding: 2,265,008,488
  Share Type: Namenaktie Closely Held Shares: 150,511,436
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.